Sriram SathyVice President Biology and Translational Medicine at Codiak Biosciences
Sriram Sathy is the Vice President, Biology and Translational Science at Codiak Biosciences and a distinguished scientist with more than 14 years of industry experience building, developing managing differentiated Oncology and Immuno-Oncology scientific and translational strategies. At Codiak he is responsible for building the pre-clinical pipeline. Prior to joining Codiak Sriram was Senior Director of Translational Science at Jounce, where he was responsible for building their translational science platform. Here he developed and implemented an integrated translational discovery strategy that develop patient enrichment biomarkers and indication selection and new target identification which helped transform Jounce to a publicly-traded research and development organization. Before joining Jounce, Sriram spent 6 years at Merck & Co, leading the translational oncology strategy for their multi-oncology programs that established clinical Proof of Concept (POC) for a novel combination therapy.